Titre : Calcifédiol

Calcifédiol : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Calcifédiol : Questions médicales les plus fréquentes", "headline": "Calcifédiol : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Calcifédiol : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-03", "dateModified": "2026-03-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Calcifédiol" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hydroxycholécalciférols", "url": "https://questionsmedicales.fr/mesh/D006887", "about": { "@type": "MedicalCondition", "name": "Hydroxycholécalciférols", "code": { "@type": "MedicalCode", "code": "D006887", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.938.146.478" } } }, "about": { "@type": "MedicalCondition", "name": "Calcifédiol", "alternateName": "Calcifediol", "code": { "@type": "MedicalCode", "code": "D002112", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Roger Bouillon", "url": "https://questionsmedicales.fr/author/Roger%20Bouillon", "affiliation": { "@type": "Organization", "name": "Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, Catholic University of Leuven, 3000 Leuven, Belgium." } }, { "@type": "Person", "name": "Maria Luisa Brandi", "url": "https://questionsmedicales.fr/author/Maria%20Luisa%20Brandi", "affiliation": { "@type": "Organization", "name": "Fondazione Italiana Ricerca Sulle Malattie dell'Osso (FIRMO Onlus), 50129 Florence, Italy." } }, { "@type": "Person", "name": "Akhtar Ashfaq", "url": "https://questionsmedicales.fr/author/Akhtar%20Ashfaq", "affiliation": { "@type": "Organization", "name": "OPKO Health, Inc., Miami, Florida, USA." } }, { "@type": "Person", "name": "Marta Entrenas-Castillo", "url": "https://questionsmedicales.fr/author/Marta%20Entrenas-Castillo", "affiliation": { "@type": "Organization", "name": "Pneumology Department, Hospital QuironSalud, 14004 Cordoba, Spain." } }, { "@type": "Person", "name": "Charles W Bishop", "url": "https://questionsmedicales.fr/author/Charles%20W%20Bishop", "affiliation": { "@type": "Organization", "name": "OPKO Health, Inc., Miami, Florida, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Association between serum 25-hydroxyvitamin D and fasting blood glucose in osteoporosis patients.", "datePublished": "2023-11-01", "url": "https://questionsmedicales.fr/article/37914715", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-45504-6" } }, { "@type": "ScholarlyArticle", "name": "Social determinants of serum 25-hydroxyvitamin D concentrations deficiency in older Chilean people.", "datePublished": "2023-10-26", "url": "https://questionsmedicales.fr/article/37884637", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-45862-1" } }, { "@type": "ScholarlyArticle", "name": "Evaluating the effect of body mass index and 25-hydroxy-vitamin D level on basal cell carcinoma using Mendelian randomization.", "datePublished": "2023-10-02", "url": "https://questionsmedicales.fr/article/37783777", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-43926-w" } }, { "@type": "ScholarlyArticle", "name": "Interaction of estradiol and vitamin D with low skeletal muscle mass among middle-aged and elderly women.", "datePublished": "2023-09-15", "url": "https://questionsmedicales.fr/article/37715186", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12905-023-02646-z" } }, { "@type": "ScholarlyArticle", "name": "Meta-Analysis of European Clinical Trials Characterizing the Healthy-Adult Serum 25-hydroxyvitamin D Response to Vitamin D Supplementation.", "datePublished": "2023-09-14", "url": "https://questionsmedicales.fr/article/37764770", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/nu15183986" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Lipides", "item": "https://questionsmedicales.fr/mesh/D008055" }, { "@type": "ListItem", "position": 3, "name": "Lipides membranaires", "item": "https://questionsmedicales.fr/mesh/D008563" }, { "@type": "ListItem", "position": 4, "name": "Stérols", "item": "https://questionsmedicales.fr/mesh/D013261" }, { "@type": "ListItem", "position": 5, "name": "Cholécalciférol", "item": "https://questionsmedicales.fr/mesh/D002762" }, { "@type": "ListItem", "position": 6, "name": "Hydroxycholécalciférols", "item": "https://questionsmedicales.fr/mesh/D006887" }, { "@type": "ListItem", "position": 7, "name": "Calcifédiol", "item": "https://questionsmedicales.fr/mesh/D002112" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Calcifédiol - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Calcifédiol", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-04-30", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Calcifédiol", "description": "Comment diagnostiquer une carence en calcifédiol ?\nQuels tests sont utilisés pour évaluer le calcifédiol ?\nQuels symptômes indiquent un besoin de test de calcifédiol ?\nLe calcifédiol est-il mesuré dans d'autres conditions ?\nQuelle est la plage normale de calcifédiol ?", "url": "https://questionsmedicales.fr/mesh/D002112?page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Calcifédiol", "description": "Quels sont les symptômes d'une carence en calcifédiol ?\nLa surdose de calcifédiol provoque-t-elle des symptômes ?\nComment la carence en calcifédiol affecte-t-elle les os ?\nLes symptômes de calcifédiol varient selon l'âge ?\nLe calcifédiol influence-t-il l'humeur ?", "url": "https://questionsmedicales.fr/mesh/D002112?page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Calcifédiol", "description": "Comment prévenir une carence en calcifédiol ?\nLes suppléments de calcifédiol sont-ils nécessaires ?\nLes personnes âgées doivent-elles surveiller leur calcifédiol ?\nLe mode de vie influence-t-il les niveaux de calcifédiol ?\nLes femmes enceintes doivent-elles surveiller leur calcifédiol ?", "url": "https://questionsmedicales.fr/mesh/D002112?page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Calcifédiol", "description": "Comment traiter une carence en calcifédiol ?\nQuels sont les dosages recommandés de calcifédiol ?\nLe calcifédiol est-il disponible sous forme injectable ?\nQuels aliments sont riches en calcifédiol ?\nLe traitement au calcifédiol nécessite-t-il un suivi médical ?", "url": "https://questionsmedicales.fr/mesh/D002112?page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Calcifédiol", "description": "Quelles complications peuvent survenir avec une carence en calcifédiol ?\nLa surdose de calcifédiol entraîne-t-elle des complications ?\nLes complications de calcifédiol sont-elles réversibles ?\nLes maladies chroniques augmentent-elles le risque de complications ?\nComment prévenir les complications liées au calcifédiol ?", "url": "https://questionsmedicales.fr/mesh/D002112?page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Calcifédiol", "description": "Quels sont les facteurs de risque de carence en calcifédiol ?\nLes personnes vivant en milieu urbain sont-elles à risque ?\nLes régimes végétariens augmentent-ils le risque de carence ?\nLes maladies digestives affectent-elles l'absorption du calcifédiol ?\nLes personnes âgées sont-elles plus à risque de carence ?", "url": "https://questionsmedicales.fr/mesh/D002112?page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en calcifédiol ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un dosage sanguin de calcifédiol permet de diagnostiquer une carence." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer le calcifédiol ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sanguins mesurent les niveaux de calcifédiol et de calcium." } }, { "@type": "Question", "name": "Quels symptômes indiquent un besoin de test de calcifédiol ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, douleurs osseuses et faiblesse musculaire peuvent indiquer un besoin de test." } }, { "@type": "Question", "name": "Le calcifédiol est-il mesuré dans d'autres conditions ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est mesuré dans des troubles métaboliques du calcium." } }, { "@type": "Question", "name": "Quelle est la plage normale de calcifédiol ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La plage normale est généralement de 20 à 60 ng/ml dans le sang." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une carence en calcifédiol ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, douleurs osseuses et faiblesse musculaire." } }, { "@type": "Question", "name": "La surdose de calcifédiol provoque-t-elle des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut causer nausées, vomissements et hypercalcémie." } }, { "@type": "Question", "name": "Comment la carence en calcifédiol affecte-t-elle les os ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner une déminéralisation osseuse et des fractures." } }, { "@type": "Question", "name": "Les symptômes de calcifédiol varient selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants et les personnes âgées peuvent présenter des symptômes différents." } }, { "@type": "Question", "name": "Le calcifédiol influence-t-il l'humeur ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une carence peut être liée à des troubles de l'humeur comme la dépression." } }, { "@type": "Question", "name": "Comment prévenir une carence en calcifédiol ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition suffisante au soleil et une alimentation riche en vitamine D aident." } }, { "@type": "Question", "name": "Les suppléments de calcifédiol sont-ils nécessaires ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être nécessaires, surtout en hiver ou pour les personnes à risque." } }, { "@type": "Question", "name": "Les personnes âgées doivent-elles surveiller leur calcifédiol ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont plus à risque de carence et devraient faire des tests réguliers." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il les niveaux de calcifédiol ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie actif et une bonne nutrition favorisent des niveaux adéquats." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles surveiller leur calcifédiol ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une surveillance est recommandée pour la santé de la mère et du bébé." } }, { "@type": "Question", "name": "Comment traiter une carence en calcifédiol ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut des suppléments de calcifédiol et une exposition au soleil." } }, { "@type": "Question", "name": "Quels sont les dosages recommandés de calcifédiol ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les dosages varient, mais 800 à 2000 UI par jour sont souvent recommandés." } }, { "@type": "Question", "name": "Le calcifédiol est-il disponible sous forme injectable ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le calcifédiol peut être administré par injection dans certains cas." } }, { "@type": "Question", "name": "Quels aliments sont riches en calcifédiol ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les poissons gras, les œufs et les produits laitiers sont de bonnes sources." } }, { "@type": "Question", "name": "Le traitement au calcifédiol nécessite-t-il un suivi médical ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi est essentiel pour ajuster le traitement et surveiller les niveaux." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une carence en calcifédiol ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'ostéoporose et les fractures osseuses." } }, { "@type": "Question", "name": "La surdose de calcifédiol entraîne-t-elle des complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut causer des complications comme l'hypercalcémie et des problèmes rénaux." } }, { "@type": "Question", "name": "Les complications de calcifédiol sont-elles réversibles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la plupart des complications sont réversibles avec un traitement approprié." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles le risque de complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le diabète peuvent augmenter le risque de complications." } }, { "@type": "Question", "name": "Comment prévenir les complications liées au calcifédiol ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier et un traitement adéquat aident à prévenir les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de carence en calcifédiol ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, l'obésité, et une exposition solaire insuffisante." } }, { "@type": "Question", "name": "Les personnes vivant en milieu urbain sont-elles à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la pollution et le manque d'exposition au soleil augmentent le risque." } }, { "@type": "Question", "name": "Les régimes végétariens augmentent-ils le risque de carence ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les régimes végétariens peuvent manquer de sources de vitamine D." } }, { "@type": "Question", "name": "Les maladies digestives affectent-elles l'absorption du calcifédiol ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la maladie cœliaque peuvent réduire l'absorption." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque de carence ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles ont souvent des niveaux plus bas de calcifédiol en raison de divers facteurs." } } ] } ] }

Sources (86 au total)

Evaluating the effect of body mass index and 25-hydroxy-vitamin D level on basal cell carcinoma using Mendelian randomization.

Basal cell carcinoma (BCC) is the most common cancer with a rising incidence among white-skinned individuals. A number of epidemiological studies have suggested that obesity and serum 25-hydroxy-vitam...

Interaction of estradiol and vitamin D with low skeletal muscle mass among middle-aged and elderly women.

Since the connection between muscle atrophy and vitamin D and estradiol status ambiguous, this study was thus conducted to determine whether low skeletal muscle mass (SMM) in middle-aged and elderly w... Baseline data from a sub-cohort of the China Northwest Natural Population Cohort: Ningxia Project (CNC-NX) were analyzed. Serum 25-hydroxyvitamin D (25(OH) D) and estradiol were measured by chemilumin... A total of 287 (9.49%) participants had low SMM, which had lower levels of estradiol and vitamin D concentration than normal SMM group. While, after adjusting the confounding variables, these correlat... Estradiol and vitamin D were interrelated with low SMM in middle-aged and elderly women. Combination of estradiol and vitamin D supplements should be encouraged for middle-aged and elderly women who a...

Association of serum 25-hydroxyvitamin D with urinary incontinence in elderly men: evidence based on NHANES 2007-2014.

The correlation between serum 25-hydroxyvitamin D (25(OH)D) and different sub-types of urinary incontinence in elderly men continues to be uncertain. Hence, we performed this research to evaluate whet... The present study incorporated the male population aged 50 years and above from four cycles of the NHANES database spanning from 2007 to 2014, for the purpose of analysis. The assessment of urinary in... Ultimately, a sum of 4663 elderly men were involved in our analysis. The outcomes of the univariable analysis illustrated that the group with vitamin D deficiency exhibited augmented odds of all three... Decreased serum 25(OH)D levels were connected with stress urinary incontinence and mixed urinary incontinence in elderly men....

Association between serum 25- hydroxyvitamin D and albuminuiria in middle-aged and older Chinese patients with type 2 diabetes.

The objective was to analyze the relationship between serum 25-hydroxy-vitamin D (25(OH)D) level and albuminuiria in middle-aged and older patients with type 2 diabetes of Gansu Province.... Data pertaining to 380 in-patients with type 2 diabetes were collected. Subjects were classified groups based on gender,age,25(OH)D,BMI and UACR.Serum 25(OH)D and other clinical characteristics among ... Out of the 380 subjects, 83.4%were classified as vitamin D deficiency, 14.5%were classified as vitamin D insufficiency, while 2.1% were classified as vitamin D sufficiency. Among the participants,41% ... The prevalence of vitamin D deficiency in patients with albuminuria was overtly higher than that in patients without albuminuria among middle-aged and older adults with type 2 diabetes....

Pediatric vitamin D: Pseudo-hypervitaminosis.

Vitamin D toxicity is rare in pediatric population. Falsely elevated levels of 25-hydroxyvitamin D have been reported as a major challenge with immunoassay methods for quantifying vitamin D metabolite... Here, we present two pediatric cases of falsely elevated 25-hydroxyvitamin D that resulted in unnecessary further testing. We also report significant same-day variation in the measurement of 25-hydrox... The addition of a centrifugation step prior to sample testing resolved the variation observed in the measurement of 25-hydroxyvitamin D levels. The patient samples were confirmed with instruments from...

Parathyroid hormone-vitamin D dynamics vary according to the definition of vitamin D deficiency in newborn infants.

Parathyroid hormone (PTH) is an indirect functional indicator of vitamin D status. Risk of vitamin D deficiency, assessed using circulating 25-hydroxyvitamin D (25(OH)D), is defined as <30 nmol/L by t... To test PTH concentrations and the odds for elevated values according to vitamin D deficiency cut-points (<30 nmol/L, or <25 nmol/L) in newborn infants.... Healthy term-born infants (n = 858) were recruited from Montreal, Canada (2016-2019). Obstetric data were obtained from medical records, and demographic factors surveyed. Immunoassays were used to mea... Infants (50.2 % female) were 39.6 ± 1.0 weeks gestational age (mean ± SD), and 3.41 ± 0.38 kg. Median serum 25(OH)D was 45.4 (IQR 23.2) nmol/L; 20.5 % had serum 25(OH)D < 30 nmol/L, and 12.4 % <25 nmo... Based on this study, the definition of vitamin D deficiency relative to bone health as set by the National Academy of Medicine (<30 nmol/L) exceeds the threshold at which PTH is elevated in newborn in...